COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $285 | +4.8% | 12,765 | +0.8% | 0.00% | – |
| Q2 2023 | $272 | -33.7% | 12,659 | -25.9% | 0.00% | -100.0% |
| Q1 2023 | $410 | -30.2% | 17,087 | -32.4% | 0.00% | 0.0% |
| Q4 2022 | $587 | -99.9% | 25,286 | -55.0% | 0.00% | 0.0% |
| Q3 2022 | $900,000 | -16.7% | 56,176 | -7.9% | 0.00% | 0.0% |
| Q2 2022 | $1,080,000 | -3.4% | 60,971 | +11.1% | 0.00% | 0.0% |
| Q1 2022 | $1,118,000 | +160.0% | 54,892 | +138.7% | 0.00% | – |
| Q4 2021 | $430,000 | -21.8% | 22,994 | -17.5% | 0.00% | -100.0% |
| Q3 2021 | $550,000 | -27.9% | 27,865 | -13.7% | 0.00% | 0.0% |
| Q2 2021 | $763,000 | +0.7% | 32,294 | +0.9% | 0.00% | 0.0% |
| Q1 2021 | $758,000 | +18.3% | 32,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $641,000 | -3.8% | 32,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $666,000 | +18.9% | 32,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $560,000 | +7.1% | 32,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $523,000 | -20.6% | 32,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $659,000 | +63.9% | 32,000 | -8.6% | 0.00% | 0.0% |
| Q3 2019 | $402,000 | -12.6% | 35,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $460,000 | +10.8% | 35,000 | +27.7% | 0.00% | 0.0% |
| Q1 2019 | $415,000 | -11.7% | 27,400 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $470,000 | -2.5% | 27,400 | -16.2% | 0.00% | 0.0% |
| Q3 2018 | $482,000 | -57.8% | 32,700 | -31.6% | 0.00% | 0.0% |
| Q2 2018 | $1,141,000 | +2.6% | 47,833 | +9.9% | 0.00% | 0.0% |
| Q1 2018 | $1,112,000 | +53.2% | 43,533 | +10.7% | 0.00% | 0.0% |
| Q4 2017 | $726,000 | +185.8% | 39,333 | +62.5% | 0.00% | – |
| Q3 2017 | $254,000 | -16.2% | 24,200 | 0.0% | 0.00% | – |
| Q2 2017 | $303,000 | +91.8% | 24,200 | +54.1% | 0.00% | – |
| Q1 2017 | $158,000 | -26.5% | 15,701 | +13.8% | 0.00% | – |
| Q4 2016 | $215,000 | -19.2% | 13,800 | 0.0% | 0.00% | – |
| Q3 2016 | $266,000 | +62.2% | 13,800 | 0.0% | 0.00% | – |
| Q2 2016 | $164,000 | -0.6% | 13,800 | +51.5% | 0.00% | – |
| Q1 2016 | $165,000 | -1.8% | 9,108 | +49.3% | 0.00% | – |
| Q4 2015 | $168,000 | +24.4% | 6,100 | 0.0% | 0.00% | – |
| Q3 2015 | $135,000 | +84.9% | 6,100 | +49.7% | 0.00% | – |
| Q2 2015 | $73,000 | – | 4,076 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
| Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
| Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
| GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
| RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
| Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
| CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
| EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
| ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |